The Battle over mTOR: An Emerging Theatre in Host–Pathogen Immunity

Mammalian target of rapamycin (mTOR) kinases are emerging as master regulators of cellular metabolism [1]. During an infection, pathogens seek nutrition to survive and often exploit host machinery that controls cellular metabolic processes. Moreover, pathogens can subvert host metabolism by targeting mTOR complexes to gain a replicative advantage. Conversely, host cells regulate the mTOR axis to facilitate pathogen clearance. Intriguingly, in addition to their role in the regulation of metabolism, mTOR complexes regulate both the quality and quantity of innate and adaptive immune responses. Here we propose that drugs strategically targeting mTOR, perhaps in opposing ways in distinct cell types, could influence the immunological outcome of host–pathogen interactions and also act as effective antibiotics by limiting pathogen replication.

[1]  M. Gougeon,et al.  HMGB1, an alarmin promoting HIV dissemination and latency in dendritic cells , 2011, Cell Death and Differentiation.

[2]  T. Roberts,et al.  Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner , 2007, Proceedings of the National Academy of Sciences.

[3]  B. Snel,et al.  Evolution of the TOR Pathway , 2011, Journal of Molecular Evolution.

[4]  J. Cheng,et al.  Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Winer,et al.  The adaptive immune system as a fundamental regulator of adipose tissue inflammation and insulin resistance , 2012, Immunology and cell biology.

[6]  Lawrence Steinman,et al.  T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis , 2010, Nature Medicine.

[7]  T. Weichhart,et al.  The multiple facets of mTOR in immunity. , 2009, Trends in immunology.

[8]  F. McCormick,et al.  Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication , 2005, The EMBO journal.

[9]  G. McFadden,et al.  Oncolytic Virotherapy Synergism with Signaling Inhibitors: Rapamycin Increases Myxoma Virus Tropism for Human Tumor Cells , 2006, Journal of Virology.

[10]  Rohan Kamat,et al.  Cholesterol depletion associated with Leishmania major infection alters macrophage CD40 signalosome composition and effector function , 2009, Nature Immunology.

[11]  M. Horton,et al.  Regulation of immune responses by mTOR. , 2012, Annual review of immunology.

[12]  J. Gordon,et al.  Human nutrition, the gut microbiome and the immune system , 2011, Nature.

[13]  Anne E Carpenter,et al.  mTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway , 2011, Cell.

[14]  A. Levine,et al.  Role of T antigen interactions with p53 in tumorigenesis. , 2001, Seminars in cancer biology.

[15]  O. Schwartz,et al.  Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. , 2010, Immunity.

[16]  J. Alwine,et al.  Human Cytomegalovirus Infection Maintains mTOR Activity and Its Perinuclear Localization during Amino Acid Deprivation , 2011, Journal of Virology.

[17]  D. Sabatini,et al.  mTOR: from growth signal integration to cancer, diabetes and ageing , 2010, Nature Reviews Molecular Cell Biology.

[18]  C. Thompson,et al.  The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.

[19]  D. Walsh,et al.  Regulation of the Translation Initiation Factor eIF4F by Multiple Mechanisms in Human Cytomegalovirus-Infected Cells , 2005, Journal of Virology.

[20]  S. Kudchodkar,et al.  Effects of Simian Virus 40 Large and Small Tumor Antigens on Mammalian Target of Rapamycin Signaling: Small Tumor Antigen Mediates Hypophosphorylation of eIF4E-Binding Protein 1 Late in Infection , 2005, Journal of Virology.

[21]  D. Walsh,et al.  Eukaryotic Translation Initiation Factor 4F Architectural Alterations Accompany Translation Initiation Factor Redistribution in Poxvirus-Infected Cells , 2008, Molecular and Cellular Biology.

[22]  K. Stuhlmeier,et al.  The TSC-mTOR signaling pathway regulates the innate inflammatory response. , 2008, Immunity.

[23]  Yang Ke,et al.  Human Papillomavirus 16 E6 Oncoprotein Interferences with Insulin Signaling Pathway by Binding to Tuberin* , 2004, Journal of Biological Chemistry.

[24]  P. Worley,et al.  The mammalian Target of Rapamycin (mTOR) regulates T helper cell differentiation through the selective activation of mTORC1 and mTORC2 signaling , 2011, Nature Immunology.

[25]  A. Awasthi,et al.  Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses , 2004, Nature Medicine.

[26]  R. Ahmed,et al.  mTOR regulates memory CD8 T cell differentiation , 2009, Nature.

[27]  L. Weiss,et al.  Coordinate Control of Host Centrosome Position, Organelle Distribution, and Migratory Response by Toxoplasma gondii via Host mTORC2* , 2010, The Journal of Biological Chemistry.

[28]  Craig B. Thompson,et al.  Fuel feeds function: energy metabolism and the T-cell response , 2005, Nature Reviews Immunology.

[29]  B. Pulendran,et al.  Vesicular stomatitis virus oncolysis is potentiated by impairing mTORC1-dependent type I IFN production , 2010, Proceedings of the National Academy of Sciences.

[30]  J. Alwine,et al.  The Changing Role of mTOR Kinase in the Maintenance of Protein Synthesis during Human Cytomegalovirus Infection , 2011, Journal of Virology.

[31]  D. Walsh,et al.  Noncytotoxic Inhibition of Viral Infection through eIF4F-Independent Suppression of Translation by 4EGi-1 , 2010, Journal of Virology.

[32]  Y. Natkunam,et al.  Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas. , 2003, Cancer research.

[33]  K. Shokat,et al.  Constitutive mTORC1 activation by a herpesvirus Akt surrogate stimulates mRNA translation and viral replication. , 2010, Genes & development.

[34]  B. Hemmings,et al.  Protein kinase B/Akt is activated by polyomavirus middle-T antigen via a phosphatidylinositol 3-kinase-dependent mechanism , 1998, Oncogene.

[35]  S. Kudchodkar,et al.  AMPK-Mediated Inhibition of mTOR Kinase Is Circumvented during Immediate-Early Times of Human Cytomegalovirus Infection , 2007, Journal of Virology.

[36]  A. Miyajima,et al.  GM‐CSF triggers a rapid, glucose dependent extracellular acidification by TF‐1 cells: Evidence for sodium/proton antiporter and PKC mediated activation of acid production , 1993, Journal of cellular physiology.

[37]  David R. Plas,et al.  Growth Factors Can Influence Cell Growth and Survival through Effects on Glucose Metabolism , 2001, Molecular and Cellular Biology.

[38]  D. Walsh,et al.  Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells. , 2004, Genes & development.

[39]  D. Pim,et al.  Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A , 2005, Oncogene.

[40]  N. McMillan,et al.  Papillomavirus virus-like particles activate the PI3-kinase pathway via alpha-6 beta-4 integrin upon binding. , 2006, Virology.

[41]  Leaf Huang,et al.  In vivo gene delivery by nonviral vectors: overcoming hurdles? , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  Greg M. Delgoffe,et al.  mTOR: taking cues from the immune microenvironment , 2009, Immunology.

[43]  N. Sonenberg,et al.  Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. , 2011, Cell host & microbe.

[44]  Bruce R. Blazar,et al.  Engineering lymphocyte subsets: tools, trials and tribulations , 2009, Nature Reviews Immunology.

[45]  B. Finlay,et al.  Host–microbe interactions , 2007, Nature.

[46]  Qingsheng Li,et al.  A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity. , 2011, Immunity.